1. Home
  2. SUPN vs HEES Comparison

SUPN vs HEES Comparison

Compare SUPN & HEES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • HEES
  • Stock Information
  • Founded
  • SUPN 2005
  • HEES 1961
  • Country
  • SUPN United States
  • HEES United States
  • Employees
  • SUPN N/A
  • HEES N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • HEES Misc Corporate Leasing Services
  • Sector
  • SUPN Health Care
  • HEES Industrials
  • Exchange
  • SUPN Nasdaq
  • HEES Nasdaq
  • Market Cap
  • SUPN 1.9B
  • HEES 2.1B
  • IPO Year
  • SUPN 2012
  • HEES 2006
  • Fundamental
  • Price
  • SUPN $37.77
  • HEES $59.25
  • Analyst Decision
  • SUPN Hold
  • HEES Buy
  • Analyst Count
  • SUPN 1
  • HEES 6
  • Target Price
  • SUPN $36.00
  • HEES $61.25
  • AVG Volume (30 Days)
  • SUPN 393.7K
  • HEES 329.0K
  • Earning Date
  • SUPN 11-04-2024
  • HEES 10-29-2024
  • Dividend Yield
  • SUPN N/A
  • HEES 1.84%
  • EPS Growth
  • SUPN 130.79
  • HEES N/A
  • EPS
  • SUPN 1.07
  • HEES 3.94
  • Revenue
  • SUPN $651,972,000.00
  • HEES $1,518,307,000.00
  • Revenue This Year
  • SUPN $7.82
  • HEES $4.55
  • Revenue Next Year
  • SUPN N/A
  • HEES $3.91
  • P/E Ratio
  • SUPN $35.57
  • HEES $15.05
  • Revenue Growth
  • SUPN 6.79
  • HEES 5.69
  • 52 Week Low
  • SUPN $25.53
  • HEES $40.92
  • 52 Week High
  • SUPN $39.37
  • HEES $66.18
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 70.18
  • HEES 66.57
  • Support Level
  • SUPN $35.87
  • HEES $50.15
  • Resistance Level
  • SUPN $39.37
  • HEES $60.75
  • Average True Range (ATR)
  • SUPN 1.54
  • HEES 1.91
  • MACD
  • SUPN 0.28
  • HEES 0.49
  • Stochastic Oscillator
  • SUPN 73.06
  • HEES 85.85

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About HEES H&E Equipment Services Inc.

H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.

Share on Social Networks: